The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease

Kuk Kim, Hyun; S. Tantry, Udaya; C. Smith, Sidney; Ho Jeong, Myung; Park, Seung‐Jung; Hyun Kim, Moo; Lim, Do‐Sun; Shin, Eun‐Seok; Park, Duk‐Woo; Huo, Yong; Chen, Shao-Liang; Zheng, Bo; Goto, Shinya; Kimura, Takeshi; Yasuda, Satoshi; Chen, Wen‐Jone; Y. Chan, Mark; Aradi, Dániel; Geisler, Tobias; A. Gorog, Diana; Sibbing, Dirk; Y.H. Lip, Gregory; J. Angiolillo, Dominick; A. Gurbel, Paul; Jeong, Young‐Hoon

doi:10.1055/s-0040-1718729

Public

The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease

Published in Thrombosis and Haemostasis • Nov 10, 2020

Authors:

Hyun Kuk Kim

Udaya S. Tantry

Sidney C. Smith

Abstract

Abstract East Asian patients have reduced anti-ischemic benefits and increased bleeding risk during antithrombotic therapies compared with Caucasian patients. As potent P2Y12 receptor inhibitors (e.g., ticagrelor and prasugrel) and direct oral anticoagulants are commonly used in current daily practi...

Subject

Ticagrelor

Antithrombotic

Prasugrel

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!